Hautien Liou, MD
Transplant Surgery · New York, NYNPI 1801231055
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,086 of the $31,430 with a category attached, or 89.4%. Surgical Specialties Corporation (US), Inc. (dba Corza Medical) accounts for 91.7% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $19,028, more than ten times the $521 reported in 2019. Among transplant surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $730.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$29K
- Intuitive Surgical$618
- Davol Inc.$515
- Ipsen Biopharmaceuticals, Inc$328
- Paragonix Technologies, Inc.$239
- Johnson & Johnson$212
- plus $695 from 9 others
What the payments were for
- Consulting fees$28,08689%
- Travel & lodging$3321%
- Food & beverage$2,5128%
- Education$5002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 9 | $28,823 |
| Intuitive Surgical | 3 | $618 |
| Davol Inc. | 6 | $515 |
| Ipsen Biopharmaceuticals, Inc | 7 | $328 |
| Paragonix Technologies, Inc. | 1 | $239 |
| Johnson & Johnson | 4 | $212 |
| Organox Ltd | 1 | $172 |
| Olympus America Inc. | 2 | $154 |
| Intra-sana Laboratories | 1 | $114 |
| Fujifilm Healthcare Americas Corporation | 1 | $83 |
| Mirum Pharmaceuticals, Inc. | 3 | $71 |
| Mallinckrodt Hospital Products Inc. | 2 | $39 |
| Boston Scientific | 1 | $22 |
| Orphalan Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,430 in reported general payments places this provider in the 90th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in New York
- Kishore IyerNew York$95K
- Jason HawksworthNew York$91K
- Parissa TabrizianNew York$74K
- Lloyd RatnerNew York$32K
- Karim HalazunNew York$28K
- Myron SchwartzNew York$27K
- Ron ShapiroNew York$16K
- Gabriel GondolesiNew York$15K
- Lewis TepermanNew York$13K
- Babak OrandiNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.